Digestive Diseases and Sciences

, Volume 51, Issue 12, pp 2113–2120 | Cite as

Studying the Overlap Between IBS and GERD: A Systematic Review of the Literature

  • Igor Nastaskin
  • Edgar Mehdikhani
  • Jeffrey Conklin
  • Sandy Park
  • Mark PimentelEmail author
Original Paper


Evidence points to a significant overlap between irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). In this study, we evaluate this overlap by conducting a systematic review of the literature. Six electronic databases from 1966 through January 2005 were screened by multiple search terms to identify all epidmiological evidence linking IBS and GERD. In addition, AGA meeting abstracts for 2003 and 2004 were also screened. All studies were validated by the authors and data extracted according to predefined criteria. As a separate search strategy, studies evaluating the prevalence of IBS and GERD in the general population were sought. These articles were obtained to compare the prevalence of IBS and GERD in the community to the degree of overlap. The search identified 997 original titles with 15 publications that fulfilled our eligibility criteria. Among the 15 studies, 7 determined the GERD maximum mean prevalence in patients already diagnosed with IBS to be 39.3% and the weighted mean 30.3%. The other 7 studies examined the prevalence of IBS in patients already diagnosed with GERD. The maximum mean prevalence of IBS in subjects with known GERD was 48.8% and the weighted mean 60.5%. Based on the prevalence of IBS (12.1%) and GERD (19.4%) in the community, the rate of IBS in the non-GERD community was calculated to be only 5.1%. There is a strong overlap between GERD and IBS that exceeds the individual presence of each condition. In the absence of GERD, IBS is relatively uncommon.


Irritable bowel syndrome Gastroesophageal reflux disease Functional bowel disease 



This work was supported in part by the Beatrice and Samuel A. Seaver Foundation.


  1. 1.
    Isolauri J, Laippala P (1995) Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 27:67–70PubMedGoogle Scholar
  2. 2.
    Valle C, Broglia F, Pistorio A, et al. (1999) Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 44:1848–1852CrossRefPubMedGoogle Scholar
  3. 3.
    Saito YA, Locke GR, Talley NJ, et al. (2000) A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 95:2816–24CrossRefPubMedGoogle Scholar
  4. 4.
    Whorwell PJ, McCallum M, Creed FH, Roberts CT (1986) Non-colonic features of irritable bowel syndrome. Gut 27:37–40PubMedGoogle Scholar
  5. 5.
    Talley NJ, Dennis EH, Schettler-Duncan VA, et al. (2003) Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 98:2454–2459CrossRefPubMedGoogle Scholar
  6. 6.
    Pimentel M, Rossi F, Chow EJ, et al. (2002) Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol 34:221–224CrossRefPubMedGoogle Scholar
  7. 7.
    Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, Egide MS (1982) Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 307:1547–1552PubMedCrossRefGoogle Scholar
  8. 8.
    Cann PA, Read NW, Brown C, et al. (1983) Irritable bowel syndrome: relationship of disorders in the transit of a single meal to symptom patterns. Gut 24:405–411PubMedGoogle Scholar
  9. 9.
    Vassallo M, Camilleri M, Phillips SF, et al. (1992) Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 102:102–108PubMedGoogle Scholar
  10. 10.
    Horikawa Y, Mieno H, Inoue M, Kajiyama G (1999) Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers. Scand J Gastroenterol 34:1190–1195CrossRefPubMedGoogle Scholar
  11. 11.
    Hebden JM, Blackshaw E, D’Amato M, et al. (2002) Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol 97:2315–2320CrossRefPubMedGoogle Scholar
  12. 12.
    Lu CL, Chen CY, Change FY, Lee SD (1998) Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an oriental study. Clin Sci 95:165–169CrossRefPubMedGoogle Scholar
  13. 13.
    Pimentel M, Soffer EE, Chow EJ, Lin HC (2002) Lower frequency of MMC is found in IBS subjects with abnormal breath test suggesting bacterial overgrowth. Dig Dis Sci 47:2639–2643CrossRefPubMedGoogle Scholar
  14. 14.
    Abrahamsson H (1987) Gastrointestinal motility in patients with irritable bowel syndrome. Scand J Gastroenterol 130:21–26Google Scholar
  15. 15.
    Svedlund J, Sjodin I, Doteval G, Gillberg R (1985) Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol 20:595–601PubMedGoogle Scholar
  16. 16.
    Smart HL, Nicholson DA, Atkinson M (1986) Gastro-oesophageal reflux in the irritable bowel syndrome. Gut 27:1127–1131PubMedGoogle Scholar
  17. 17.
    Kennedy TM, Jones RH, Hungin AP, et al. (1998) Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 43:770–774PubMedCrossRefGoogle Scholar
  18. 18.
    Stanghellini V, Tosetti C, Barbara G, et al. (2002) Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 97:2738–2743CrossRefPubMedGoogle Scholar
  19. 19.
    Hungin AP, Whorwel PJ, Tack J, Mearin F (2003) The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 17:643–650CrossRefPubMedGoogle Scholar
  20. 20.
    Jones R, Lydeard S (1992) Irritable bowel syndrome in the general population. Br Med J 304:87–90CrossRefGoogle Scholar
  21. 21.
    Bueno L, Guillemot F, Ducrotte P (2004) Are functional GI disorders often associated with GERD? Results of French survey involving 3,300 adult patients presenting with GERD. Gastroenterology 126:A376CrossRefGoogle Scholar
  22. 22.
    Chey WD, Nojkov B, Adlis S, et al. (2004) Does co-morbid irritable bowel syndrome influence the effectiveness of PPI therapy for gastroesophageal reflux disease? Gastroenterology 126:A641–A642CrossRefGoogle Scholar
  23. 23.
    Wu JC, Cheung CM, Ching JY, et al. (2004) Overlapping functional gastrointestinal disorders in patients with gastroesophageal reflux disease (GERD). Gastroenterology 126:A373CrossRefGoogle Scholar
  24. 24.
    Wu JC, Cheung Cm, Hung LC, et al. (2004) Impact of irritable bowel syndrome on clinical features and treatment response in patients with gastroesophageal reflux disease. Gastroenterology 124:A537CrossRefGoogle Scholar
  25. 25.
    Raftopoulos Y, Papasavas P, Landreneau R, et al. (2004) Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc 18:655–659CrossRefPubMedGoogle Scholar
  26. 26.
    Zimmerman J (2004) Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 20:1297–1303CrossRefPubMedGoogle Scholar
  27. 27.
    Talley NJ, Piper DW (1985) The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol 20:896–900PubMedGoogle Scholar
  28. 28.
    Mold JW, Reed LE, Davis AB, et al. (1991) Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 86:965–970PubMedGoogle Scholar
  29. 29.
    Ruth M, Mansson I, Sandberg N (1991) The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 26:73–81PubMedGoogle Scholar
  30. 30.
    Locke GR III, Talley NJ, Fett SL, et al. (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448–1456CrossRefPubMedGoogle Scholar
  31. 31.
    Haque M, Wyeth JW, Stace NH, et al. (2000) Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. NZ Med J 113:178–181Google Scholar
  32. 32.
    Kennedy T, Jones R (2000) The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 14:1589–1594CrossRefPubMedGoogle Scholar
  33. 33.
    Pan G, Xu G, Ke M, et al. (2000) Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis 1:2–8CrossRefGoogle Scholar
  34. 34.
    Strobel O, Uhl W, Scholz T, Buchler MW (2001) Surgery of reflux esophagitis—a renaissance. Ther Umschau 58(3):151–157CrossRefGoogle Scholar
  35. 35.
    Louis E, DeLooze D, Deprez P, et al. (2002) Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 14:279–284CrossRefPubMedGoogle Scholar
  36. 36.
    Khoshbaten M (2003) Gastro-esophageal reflux disease in northwestern Tabriz, Iran. Indian J Gastroenterol 22:138–139PubMedGoogle Scholar
  37. 37.
    Wong WM, Lai KC, Lam KF, et al. (2003) Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 18:595–604CrossRefPubMedGoogle Scholar
  38. 38.
    Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, et al. (2004) Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 19:95–105CrossRefPubMedGoogle Scholar
  39. 39.
    Camilleri M, Dubois D, Coulie B, et al. (2005) Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 3:543–552CrossRefPubMedGoogle Scholar
  40. 40.
    Dapoigny M, Bellanger J, Bonaz B, et al. (2004) Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 16:995–1001CrossRefPubMedGoogle Scholar
  41. 41.
    Bommelaer G, Poynard T, Le Pen C, et al. (2004) Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 28:554–561PubMedCrossRefGoogle Scholar
  42. 42.
    Wilson S, Roberts L, Roalfe A, et al. (2004) Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 54:495– 502PubMedGoogle Scholar
  43. 43.
    Gwee KA, Wee S, Wong ML, Png DJ (2004) The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol 99:924–931CrossRefPubMedGoogle Scholar
  44. 44.
    Caballero-Plasencia AM, Sofos-Kontoyannis S, Valenzuela-Barranco M, et al. (1999) Irritable bowel syndrome in patients with dyspepsia: a community-based study in southern Europe. Eur J Gastroenterol Hepat 11:517–522Google Scholar
  45. 45.
    Agreus L, Svardsudd K, Nyren O, et al. (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109:671–680CrossRefPubMedGoogle Scholar
  46. 46.
    Klauser AG. Schindlbeck NE, Muller-Lissner SA (1990) Symptoms in gastro-oesophageal reflux disease. Lancet 335:205–208CrossRefPubMedGoogle Scholar
  47. 47.
    Quigley EM (2003) Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98:S24–S30CrossRefPubMedGoogle Scholar
  48. 48.
    Salvioli B, Serra J, Azpiroz F, et al. (2005) Origin of gas retention and symptoms in patients with bloating. Gastrenterology 128:574–579CrossRefGoogle Scholar
  49. 49.
    Thompson WG, Longstreth GF, Drossman DA, et al. (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43–II47PubMedCrossRefGoogle Scholar
  50. 50.
    Whitehead WE, Holtkotter B, Enck P, et al. (1990) Tolerance for rectosigmoid distension in irritable bowel syndrome. Gastroenterology 98:1187–1192PubMedGoogle Scholar
  51. 51.
    Constantini M, Sturniolo GC, Zaninotto G, et al. (1993) Altered esophageal pain threshold in irritable bowel syndrome. Gut 38:206–212Google Scholar
  52. 52.
    Tack J, Fass R (2004) Review article: approaches to endoscopic-negative reflux disease: Part of the GERD spectum or a unique acid-related disorder? Aliment Pharmacol Ther 19:28–34CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Igor Nastaskin
    • 1
  • Edgar Mehdikhani
    • 1
  • Jeffrey Conklin
    • 1
  • Sandy Park
    • 1
  • Mark Pimentel
    • 1
    • 2
    Email author
  1. 1.Cedars-Sinai Medical CenterBurns and Allen Research Institute, and UCLA Geffen School of MedicineLos AngelesUSA
  2. 2.GI Motility LaboratoryCedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations